Article Details
Retrieved on: 2025-02-23 11:21:50
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses advancements in regenerative medicine through the use of reprogrammed vascular endothelial cells (R-VECs) to support pancreatic islet cell transplants for type 1 diabetes management, emphasizing improved outcomes over traditional methods.
Article found on: ana.ir
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here